Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -6.5 million
▲ 87% vs 2024
Profit
Caution€ -12 million
▲ 80% vs 2024
Debts
High€ 130.5 million
▲ 9% vs 2024
SYNDESI THERAPEUTICS from Wavre, company number BE0686599355, closed financial year 2025 with a result of € -12 million after tax. For that financial year SYNDESI THERAPEUTICS recorded a gross margin of € -6.5 million and equity of € -129.9 million. Compared with financial year 2024, the result moved from € -60.6 million to € -12 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
What happened at SYNDESI THERAPEUTICS?
What happened at SYNDESI THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Erica Silbiger stepped down as director. NBB
- Renaud Decroix stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 12 million. Source: NBB ↗
- Erica Silbiger became a director. NBB
- Rolfe van de Spreng stepped down as director. NBB
- Rolfe van de Spreng became a director. NBB
- Jean Antoine de Los Frailes stepped down as director. NBB
- Jean Antoine de Los Frailes became a director. NBB
In short
From € 6.3 million loss in 2021 to € 12 million loss in 2025.
A new publication or filing at SYNDESI THERAPEUTICS? We notify you, reason included.
Follow SYNDESI THERAPEUTICSNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Avenue Einstein 14
1300 Wavre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
ABBVIE - AbbVie, Inc., US
Domain
Domain
syndesitherapeutics.com
Registered
2017-12-10
Registrar
MarkMonitor Inc.
Expires
2026-12-10
Website info
Features
Security
Details
- Company number
- 0686.599.355
- VAT number
- BE 0686.599.355
- Registered office
- Avenue Einstein 14, 1300 Wavre
- Names & denominations
- SYNDESI THERAPEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 2017
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied